BrightSpring Health Services, Inc.

NasdaqGS:BTSG Stock Report

Market Cap: US$3.3b

BrightSpring Health Services Past Earnings Performance

Past criteria checks 0/6

BrightSpring Health Services's earnings have been declining at an average annual rate of -53.5%, while the Healthcare industry saw earnings growing at 5.3% annually. Revenues have been growing at an average rate of 15.8% per year.

Key information

-53.5%

Earnings growth rate

-50.0%

EPS growth rate

Healthcare Industry Growth8.5%
Revenue growth rate15.8%
Return on equity-2.7%
Net Margin-0.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

A Piece Of The Puzzle Missing From BrightSpring Health Services, Inc.'s (NASDAQ:BTSG) 26% Share Price Climb

Nov 07
A Piece Of The Puzzle Missing From BrightSpring Health Services, Inc.'s (NASDAQ:BTSG) 26% Share Price Climb

Results: BrightSpring Health Services, Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts

Nov 06
Results: BrightSpring Health Services, Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts

BrightSpring Health Services: A Promising Rally Amid Strong Q3 Results

Nov 05

Here's Why BrightSpring Health Services (NASDAQ:BTSG) Is Weighed Down By Its Debt Load

Oct 18
Here's Why BrightSpring Health Services (NASDAQ:BTSG) Is Weighed Down By Its Debt Load

BrightSpring Health Services, Inc. (NASDAQ:BTSG) Doing What It Can To Lift Shares

Sep 12
BrightSpring Health Services, Inc. (NASDAQ:BTSG) Doing What It Can To Lift Shares

BrightSpring Health Services: Evaluating The Investment Case Seven Months Post-IPO

Aug 29

BrightSpring Health Services (NASDAQ:BTSG) Seems To Be Using A Lot Of Debt

Jul 17
BrightSpring Health Services (NASDAQ:BTSG) Seems To Be Using A Lot Of Debt

Sentiment Still Eluding BrightSpring Health Services, Inc. (NASDAQ:BTSG)

Jun 10
Sentiment Still Eluding BrightSpring Health Services, Inc. (NASDAQ:BTSG)

Revenue & Expenses Breakdown

How BrightSpring Health Services makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:BTSG Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2410,588-411,3420
30 Jun 249,938-1631,4010
31 Mar 249,374-1791,3650
31 Dec 238,826-1551,2870
30 Sep 238,422-2041,2740
30 Jun 238,147-961,1480
31 Mar 237,865-881,1320
31 Dec 227,721-541,1260
30 Sep 227,551171,1350
30 Jun 227,306571,1010
31 Mar 227,002531,0640
31 Dec 216,698501,0140
30 Sep 216,366349490
30 Jun 216,043329150
31 Mar 215,812268920
31 Dec 205,580218840
31 Dec 194,525-727250
31 Dec 182,536-83040

Quality Earnings: BTSG is currently unprofitable.

Growing Profit Margin: BTSG is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: BTSG is unprofitable, and losses have increased over the past 5 years at a rate of 53.5% per year.

Accelerating Growth: Unable to compare BTSG's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BTSG is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.3%).


Return on Equity

High ROE: BTSG has a negative Return on Equity (-2.66%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies